| PF-04217903 |
| 4-[1-(6-Quinolinylmethyl)-1H-1,2,3-triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazole-1-ethanol 4-hydroxybenzenesulfonate |
| (CAS 1159490-85-3) |
 |
| Description： |
PF-04217903 is a selective ATP-competitive c-Met inhibitor with IC50 of 4.8 nM, susceptible to oncogenic mutations (no activity to Y1230C mutant).
Although unable to inhibit tumor growth in the sunitinib-sensitive B16F1 and Tib6 tumor models, the combination of PF-04217903 and sunitinib significantly inhibits tumor growth in sunitinib-resistant EL4, and LLC tumor models compared with sunitinib or PF-04217903 alone by significantly blocking vascular expansion, indicating a functional role for HGF/c-Met axis in the sunitinib-resistant tumors.
|
| Product No. |
KT00667 |
| Product Name |
PF-04217903 |
| Synonyms |
PF04217903;PF 04217903 |
| Formal Name |
4-[1-(6-Quinolinylmethyl)-1H-1,2,3-triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazole-1-ethanol 4-hydroxybenzenesulfonate |
| CAS Number |
1159490-85-3 |
| Molecular Formula |
C19H16N8O.C6H6O4S |
| Formula Weight |
546.56 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
EMD 1214063
AZD9291
CO-1686
Crizotinib
Foretinib
PHA-665752
Tivantinib
SU11274
BMS-777607 |
|
